12th BioVaria to take place on 8 9 May 2019 in Munich

12th BioVaria to take place on 8 – 9 May 2019 in Munich

On 8–9 May 2019, decision makers from biotech, pharma and finance will come together in Munich for the 12^th BioVaria to learn about commercially attractive academic inventions and initiate partnerships with research teams, entrepreneurs and technology transfer professionals from all over Europe.

66 peer-selected, patent-protected technologies originating from as many research institutes, universities and university hospitals will be featured.

Further program highlights include a panel discussion on “From stem cells to therapy: Development of cell based approaches in regenerative medicine” and BioVaria’s dedicated Startup Pitch & Partner program. The expanded format of the Startup Pitch & Partner program provides attractive opportunities for entrepreneurs and venture capitalists, with interactive pitches, one-on-one mentoring sessions and speed dating between startups and investors. Based on last year’s success it attracted more applications from European startups than ever before. A preview of all technologies selected for BioVaria 2019 and the startups selected for this year’s Startup Pitch & Partner program is available online.

BioVaria is organised by Ascenion and 14 additional technology transfer organisations from 5 European nations.

Preview BioVaria’s Technologies and Startups online

Register now at www.biovaria.org

Who should attend?

• Scouts and business developers from the international biopharmaceutical industry looking for cutting-edge inventions to complement their companies’ R&D portfolios
• Life-science investors looking for attractive startups or IP assets as investment opportunities
• Technology transfer professionals and scientists from public research institutions who have patent-protected technologies available for licensing or partnering

Patron:

Bavarian Ministry of Economic Affairs, Regional Development and Energy

Sponsors:

Bio^M, Abbvie, Else Kröner-Fresenius-Stiftung, ISAR Bioscience, Johnson & Johnson Innovation, HERTIN & Partner, Kador & Partner, NLC, Vossius & Partner

Startup Sponsors:

24IP Law Group, Accelero Bioanalytics, Charles River, German Accelerator Life Sciences, IASON Consulting, K&L Gates, LSI Life Science Inkubator, LSP, ttopstart, TVM Capital Life Science

Technology transfer partners:

Ascenion, Austria Wirtschaftsservice Gesellschaft, BayPAT, DKFZ - German Cancer Research Center, DZIF - German Center for Infection Research, EMBLEM Technology Transfer, IOCB Tech, Lead Discovery Center, LMU Munich, Max Planck Innovation, Netval, PROvendis, TechnologieAllianz, University of Pardubice, VIS

Network partners:

ASTP-Proton, BIO Deutschland, BioRN

Media partners:

Business Wire, Going Public, LABIOTECH.eu, transkript

View source version on businesswire.com: https://www.businesswire.com/news/home/20190404005356/en/

Ascenion GmbH
Esther Lange
T: +49-(0)89-318814-22
lange@ascenion.de

More From BioPortfolio on "12th BioVaria to take place on 8 – 9 May 2019 in Munich"